ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1795

IL-7 in Primary Sjogren Syndrome (pSS) Is Secreted By Salivary Gland Epithelial Cells after IFN Stimulation and Is Associated with B-Cell Activation

Alexandre Virone1, Juliette Pascaud2, Elodie Rivière1, Jacques-Eric Gottenberg3, Véronique Le Guern4, Xavier Mariette1 and Gaetane Nocturne5, 1Université Paris Sud, Paris, France, 2U1184 IMVA, Université Paris Sud, Le Kremlin-Bicêtre Cedex, France, 3CNRS, Immunopathologie et Chimie Thérapeutique/Laboratory of Excellence Medalis, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France, 4Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, 5INSERM U1184, IMVA, Paris Sud University,LabEx LERMIT, Le Kremlin Bicêtre, France

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Sjogren's syndrome, T cells and interleukins (IL)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis: Unexpected Effects from "Well-Known" Molecules

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose :

pSS is characterized by a strong IFN signature, ectopic germinal centers formation and a chronic blood lymphopenia. IL-7 plays a central part in T cells homeostasis and in lymphoid structures organization. We aimed to assess the role of IL-7 in pSS pathogenesis.

Methods :

IL-7 serum level was assessed in 372 pSS patients and 73 paired controls. Primary cultures of salivary gland epithelial cells (SGEC) from patients and controls were stimulated by Poly I:C 30 ng/ml, IFN-α 600UI/ml, IFN-γ 5ng/ml and IFN-λ (IL-28) 25ng/ml for 72 hours. IL-7 secretion was tested in culture supernatant by ELISA. IL-7 expression after 24 hours stimulation was assessed by quantitative RT-PCR. IL-7 and its receptor’s expressions were evaluated in RNA-Seq analysis from cells form salivary glands biopsies (SGB) and PBMC.

Results :

pSS patients had higher serum IL-7 levels than controls: 7.56 ng/ml ± 8.52 (mean ± SD) versus 4.86 ng/ml ± 5.59; p<0.0001. A positive correlation with B cells activation markers, IFN-induced chemokines and disease activity markers was observed. In multivariate analysis, serum IL-7 level was associated with CXCL13, anti-SSA, RF, κ light-chain and low C4.

SGEC stimulation with Poly I:C, IFN-α, -γ and -λ induced IL-7 protein secretion in the supernatant (p=0.002, p=0.004, p=0.007, p=0.004 respectively) (Figure 1). A trend for a greater IL-7 production in pSS patients compared to controls was observed. IL-7 expression was confirmed by quantitative RT-PCR. Among cell subsets purified ex vivo from SGB and PBMC, RNA-Seq analysis showed a greater expression of IL-7 by epithelial cells of patients compared to controls (p=0.03). No difference was observed regarding T and B cells either from biopsies or PBMC. IL-7 receptor expression was equivalent between patients and controls. Analysis of T cells exhaustion profile and IL-7 intracellular signaling are on-going.

Conclusion :

Our data demonstrate that IL-7 is secreted within the target tissue of pSS by SGEC after stimulation by IFNs. This IFN/IL-7 pathway can be involved in the organization of ectopic germinal centers found in pSS. But more importantly, since Il-7 is one of the major controller of homeostasis of T cells, this IFN/IL-7 pathway could be involved in the persistent lymphopenia which is a hallmark of the disease, either by favoring exhaustion of T cells or by an impaired function of the IL-7 intracellular signaling. Both mechanisms are currently explored and will be presented.


Disclosure: A. Virone, None; J. Pascaud, None; E. Rivière, None; J. E. Gottenberg, BMS, Gilead, Medimune,Pfzer SanofiAventis, Ucb, 2; V. Le Guern, None; X. Mariette, None; G. Nocturne, None.

To cite this abstract in AMA style:

Virone A, Pascaud J, Rivière E, Gottenberg JE, Le Guern V, Mariette X, Nocturne G. IL-7 in Primary Sjogren Syndrome (pSS) Is Secreted By Salivary Gland Epithelial Cells after IFN Stimulation and Is Associated with B-Cell Activation [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/il-7-in-primary-sjogren-syndrome-pss-is-secreted-by-salivary-gland-epithelial-cells-after-ifn-stimulation-and-is-associated-with-b-cell-activation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-7-in-primary-sjogren-syndrome-pss-is-secreted-by-salivary-gland-epithelial-cells-after-ifn-stimulation-and-is-associated-with-b-cell-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology